Ian Gould

Research output

Research output per year 1994 2002 2004 2019 2024

• 37 Article
• 3 Letter
• 1 Editorial

Research output per year

Research output per year

Search results

• 2024

  Methods for SARS-CoV-2 hospital disinfection, in vitro observations.

  Corzo Leon, D., Abbood, H., Colamarino, R. A., Steiner, M., Munro, C., Gould, I. & Hijazi, K., Mar 2024, In: Infection Prevention in Practice. 6, 1, 4 p., 100339.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Chlorhexidine 82%
  • Disinfection 80%
  • Ethanol 42%
  • Water 33%
• 2023

  Chlorhexidine resistance or Cross-resistance, that is the question

  Abbood, H., Hijazi, K. & Gould, I., 22 Apr 2023, In: Antibiotics. 12, 17 p., 798.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Chlorhexidine 100%
  • Disinfectants 83%
  • Antimicrobial Agent 47%
  • Biocide 42%
  • Resistance 42%
  4 Citations (Scopus)

  3 Downloads (Pure)
• 2021

  Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update

  Okoliegbe, I., Hijazi, K., Cooper, K., Ironside, C. & Gould, I., 18 May 2021, In: Antimicrobial Agents and Chemotherapy. 65, 6, 10 p., e02483-20.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Colistin 100%
  • tazobactam drug combination ceftolozane 89%
  • Cystic Fibrosis 76%
  • Lactams 74%
  • Pseudomonas aeruginosa 72%
  8 Citations (Scopus)

  4 Downloads (Pure)
• 2020

  Genomic Stability of Composite SCCmec ACME and COMER-Like Genetic Elements in Staphylococcus epidermidis Correlates With Rate of Excision

  Almebairik, N., Zamudio, R., Joshi, C., Ironside, C., Ralph, J. D., Roberts, A. P., Gould, I. M., Morrissey, J. A., Hijazi, K. & Oggioni, M. R., 12 Feb 2020, In: Frontiers in Microbiology. 11, 12 p., 166.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Staphylococcus epidermidis 100%
  • Mercury 95%
  • Genomic Instability 92%
  • Copper 84%
  • Arginine 77%
  7 Citations (Scopus)

  10 Downloads (Pure)
• 2019

  Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients

  Zamudio, R., Hijazi, K., Joshi, C., Aitken, E., Oggioni, M. R. & Gould, I. M., Jun 2019, In: International Journal of Antimicrobial Agents. 53, 6, p. 774-780 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • tazobactam drug combination ceftolozane 100%
  • ceftazidime drug combination avibactam 96%
  • Tazobactam Drug Combination Piperacillin 76%
  • Carbapenems 67%
  • Cystic Fibrosis 56%
  29 Citations (Scopus)

  6 Downloads (Pure)

• Time for biocide stewardship?

  Zamudio, R., Oggioni, M. R., Gould, I. M. & Hijazi, K., 1 May 2019, In: Nature Microbiology. 4, 5, p. 732-733 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  File
  9 Citations (Scopus)

  8 Downloads (Pure)

• An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC)

  Saeed, K., Bal, A., Gould, I., David, M. Z., Dryden, M., Giannitsioti, E., Hijazi, K., Meisner, J. A., Esposito, S., Scaglione, F., Tattevin, P. & Voss, A., Jan 2019, In: International Journal of Antimicrobial Agents. 53, 1, p. 9-15 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Endocarditis 100%
  • Staphylococcus aureus 82%
  • Drug Therapy 56%
  • Tricuspid Valve 14%
  • Coagulase 13%
  14 Citations (Scopus)

  8 Downloads (Pure)

• Challenges and opportunities for antimicrobial stewardship in resource-rich and resource-limited countries

  Hijazi, K., Joshi, C. & Gould, I. M., 2019, In: Expert Review of Anti-infective Therapy. 17, 8, p. 621-634 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Antimicrobial Stewardship 100%
  • Inappropriate Prescribing 17%
  • Delivery of Health Care 15%
  • Expert Testimony 13%
  • Consensus 12%
  16 Citations (Scopus)

  23 Downloads (Pure)
• 2018

  Hot topics in necrotising skin and soft tissue infections

  Saeed, K., Esposito, S., Gould, I., Ascione, T., Bassetti, M., Bonnet, E., Bouza, E., Chan, M., Davis, J. S., De Simone, G., Dryden, M., Gottlieb, T., Hijazi, K., Lye, D. C., Pagliano, P., Petridou, C., Righi, E., Segreti, J., Unal, S. & Yalcin, A. N., Jul 2018, In: International Journal of Antimicrobial Agents. 52, 1, p. 1-10 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File
  22 Citations (Scopus)

  9 Downloads (Pure)

• Panton–Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy

  Saeed, K., Gould, I., Espositio, S., Ahmad-Saeed, N., Ahmed, S. S., Alp, E., Bal, A. M., Bassetti, M., Bonnet, E., Chan, M., Coombs, G., Dancer, S., David, M. Z., De Simone, G., Dryden, M., Guardabassi, L., Hanitsch, L. G., Hijazi, K., Krüger, R., Lee, A., & 10 othersLeistner, R., Pagliano, P., Righi, E., Schneider-Burrus, S., Skov, R. L., Tattevin, P., Van Wamel, W., Vos, M. C., Voss, A. & International Society of Chemotherapy, Jan 2018, In: International Journal of Antimicrobial Agents. 51, 1, p. 16-25 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Leukocidins 100%
  • Staphylococcus aureus 50%
  • Drug Therapy 34%
  • Staphylococcal Pneumonia 20%
  • Methicillin 17%
  70 Citations (Scopus)

  20 Downloads (Pure)
• 2016

  Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species

  Abbott, F. K., Milne, K. E. N., Stead, D. A. & Gould, I. M., Nov 2016, In: International Journal of Antimicrobial Agents. 48, 5, p. 521-527 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Burkholderia cepacia complex 100%
  • Tobramycin 31%
  • Burkholderia cenocepacia 20%
  • Burkholderia 18%
  • Sulfamethoxazole 17%
  11 Citations (Scopus)

• Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections

  Hijazi, K., Mukhopadhya, I., Abbott, F., Milne, K., Al-Jabri, Z. J., Oggioni, M. R. & Gould, I. M., Jul 2016, In: International Journal of Antimicrobial Agents. 48, 1, p. 86-90 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Chlorhexidine 100%
  • Staphylococcus epidermidis 97%
  • Staphylococcus 50%
  • Infections 39%
  • Staphylococcus aureus 28%
  34 Citations (Scopus)

  27 Downloads (Pure)
• 2015

  Childbed fever: history repeats itself?

  Graham, W. J., Dancer, S. J., Gould, I. M. & Stones, W., Jan 2015, In: BJOG-An International Journal of Obstetrics and Gynaecology. 122, 2, p. 156-159 4 p.

  Research output: Contribution to journal › Editorial › peer-review

  • Fever 100%
  • History 99%
  • Cross Infection 88%
  • Newborn Infant 68%
  • Pessimism 63%
  7 Citations (Scopus)
• 2013

  Interventions to improve antibiotic prescribing practices for hospital inpatients

  Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J. & Wilcox, M., 30 Apr 2013, In: Cochrane Database of Systematic Reviews. 4, CD003543.

  Research output: Contribution to journal › Article › peer-review

  • Antimicrobial Stewardship 100%
  • Inpatients 60%
  • Interrupted Time Series Analysis 52%
  • Anti-Bacterial Agents 49%
  • Bacterial Infections 35%
  457 Citations (Scopus)
• 2007

  Systematic review of the effectiveness of preventing and treating Staphylococcus aureus carriage in reducing peritoneal catheter-related infections

  McCormack, K., Rabindranath, K., Kilonzo, M., Vale, L., Fraser, C., McIntyre, L., Thomas, S., Rothnie, H., Fluck, N., Gould, I. M. & Waugh, N., Jul 2007, In: Health Technology Assessment. 11, 23, p. 1-84 84 p.

  Research output: Contribution to journal › Article

  • Catheter-Related Infections 100%
  • Staphylococcus aureus 67%
  • Peritonitis 60%
  • chronic illness 58%
  • Systematic Reviews 57%
  4 Citations (Scopus)

• Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit

  Gould, I. M., MacKenzie, F. M., MacLennan, G., Pacitti, D., Watson, E. J. & Noble, D., May 2007, In: International Journal of Antimicrobial Agents. 29, 5, p. 536-543 8 p.

  Research output: Contribution to journal › Article

  • Methicillin-Resistant Staphylococcus aureus 100%
  • Intensive Care Units 81%
  • Bacteremia 16%
  • Interrupted Time Series Analysis 11%
  • Regression Analysis 10%
  58 Citations (Scopus)

• Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

  MacKenzie, F., Bruce, J., Struelens, M. J., Goossens, H., Mollison, J. A., Gould, I. M. & ARPAC Steering Group, Mar 2007, In: Clinical Microbiology and Infection. 13, 3, p. 269-276 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Drug and Narcotic Control 100%
  • Methicillin-Resistant Staphylococcus aureus 88%
  • Infection Control 87%
  • Anti-Infective Agents 16%
  • Linear Models 12%
  82 Citations (Scopus)
• 2006

  Combination antibiotic susceptibility testing in cystic fibrosis

  MacKenzie, F., Griffiths, C., Devereux, G. S. & Gould, I. M., 2006, In: The Lancet. 366

  Research output: Contribution to journal › Letter › peer-review

• Relationship between the number of different antiobiotics used and the total use of antiobiotics in European hospitals

  MacKenzie, F., Monnet, D. L., Gould, I. M., Bruce, J. & ARPAC Steering Group, 2006, In: Journal of Antimicrobial Chemotherapy. 10

  Research output: Contribution to journal › Article › peer-review

• Status of infection control policies and organisation in European hospitals, 2001: the ARPAC study

  Struelens, M. J., Wagner, D., Bruce, J., MacKenzie, F., Cookson, B., Voss, A., Van Den Broek, P. J., Gould, I. M. & ARPAC Steering Group, 2006, In: Clinical Microbiology and Infection. 12, p. 729-737 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Infection Control 100%
  • Organizations 82%
  • Workforce 42%
  • Soaps 29%
  • Hand Hygiene 29%
  37 Citations (Scopus)
• 2005

  Report of a Consensus Conference on Antibioic Resistance; Prevention and Control (ARPAC)

  MacKenzie, F., Struelens, M. J., Towner, K. J., Gould, I. M., Bruce, J. & ARPAC Steering Group, 2005, In: Clinical Microbiology and Infection. 11, 11, p. 938-954 16 p.

  Research output: Contribution to journal › Article › peer-review
  59 Citations (Scopus)

• Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases

  Nulens, E., Gould, I. M., MacKenzie, F., Deplano, A., Cookson, B., Alp, E., Bouza, E. & Voss, A., 2005, In: European Journal of Clinical Microbiology & Infectious Diseases. 24, 2, p. 145-148 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Microbiology 100%
  • Methicillin Resistance 85%
  • Staphylococcus aureus 81%
  • Communicable Diseases 80%
  • Physicians 29%
  31 Citations (Scopus)
• 2004

  Antibiograms of resistant Gram-negative bacteria from Scottish CF patients

  MacKenzie, F., Smith, S. V., Milne, K. E., Griffiths, K., Legge, J. & Gould, I. M., 2004, In: Journal of Cystic Fibrosis. 3, 3, p. 151-157 6 p.

  Research output: Contribution to journal › Article › peer-review
  18 Citations (Scopus)

• Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.

  Monnet, D. L., MacKenzie, F., Lopez-Lozano, J. M., Beyaert, A., Camacho, M., Wilson, R., Stuart, D. & Gould, I. M., 2004, In: Emerging Infectious Diseases. 10, 8, p. 1432-1441 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Methicillin-Resistant Staphylococcus aureus 100%
  • Disease Outbreaks 57%
  • Pharmaceutical Preparations 40%
  • Macrolides 18%
  • Fluoroquinolones 18%
  174 Citations (Scopus)

• Reassessment of cefaclor breakpoints for Haemophilus influenzae

  MacKenzie, F., Milne, K. E. & Gould, I. M., 2004, In: Journal of Chemotherapy. 16, 4, p. 329-333 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Cefaclor 100%
  • Haemophilus influenzae 79%
  • Microbial Sensitivity Tests 74%
  • Cefuroxime 37%
  • Streptococcus pneumoniae 7%
  1 Citation (Scopus)

• Reassessment of the cefaclor breakpoint for Streptococcus pneumoniae

  MacKenzie, F., Milne, K. E. & Gould, I. M., 2004, In: International Journal of Antimicrobial Agents. 23, 4, p. 337-342 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cefaclor 100%
  • Cefuroxime 74%
  • Streptococcus pneumoniae 71%
  • Microbial Sensitivity Tests 44%
  • Biological Assay 14%
  3 Citations (Scopus)
• 2003

  Audit of an antibiotic policy and microbiological investigations for treating bacteraemia in a large teaching hospital.

  Mackenzie, A. R., Robertson, L., Jappy, B., Laing, R. B. & Gould, I. M., 2003, In: International Journal of Antimicrobial Agents. 22, p. 618-621 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Bacteremia 100%
  • Teaching Hospitals 90%
  • Anti-Bacterial Agents 64%
  • Gram's stain 30%
  • Blood Culture 25%
  13 Citations (Scopus)

• Optimizing antibiotic therapy-the Aberdeen experience

  Kumarasamy, Y., Cadwgan, T., Gillanders, I. A., Jappy, B., Laing, R. B. & Gould, I. M., 2003, In: Clinical Microbiology and Infection. 9, 5, p. 406-411 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Anti-Bacterial Agents 100%
  • Sepsis 27%
  • Therapeutics 24%
  • Scotland 19%
  • Duration of Therapy 15%
  25 Citations (Scopus)
• 2002

  Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration

  Gould, I. M. & MacKenzie, F., 2002, In: Symposium Series/The Society for Applied Microbiology. 31, p. 78S-84S

  Research output: Contribution to journal › Article › peer-review

  51 Citations (Scopus)

• Antibiotic policies and control of resistance

  Gould, I. M., 2002, In: Current Opinion in Infectious Diseases. 15, 4, p. 395-400 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Psychological Practice 100%
  • Microbial Drug Resistance 96%
  • Anti-Bacterial Agents 95%
  • Antimicrobial Stewardship 63%
  • Pandemics 51%
  54 Citations (Scopus)

• Calculation of composite recovery time: a new pharmacodynamic parameter

  MacKenzie, F., Milne, K. E. & Gould, I. M., 2002, In: Journal of Antimicrobial Chemotherapy. 50, 2, p. 281-284 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Haemophilus influenzae 100%
  • Streptococcus pneumoniae 89%
  • Moxifloxacin 57%
  • Quinolones 50%
  • Enterobacteriaceae 48%
  1 Citation (Scopus)

• Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection

  MacKenzie, F., Miller, C. A. & Gould, I. M., 2002, In: Clinical Microbiology and Infection. 8, 11, p. 715-724 9 p.

  Research output: Contribution to journal › Article › peer-review

  • cefpodoxime 100%
  • Cefoperazone 85%
  • cefpirome 80%
  • Cefamandole 76%
  • beta-Lactamases 66%
  31 Citations (Scopus)

• Epidemic diseases in aberdeen and the history of the city hospital

  Gould, I. M., 2002, In: Journal of Infection. 44, 2

  Research output: Contribution to journal › Article › peer-review

• Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland

  MacKenzie, F., Greig, P., Edwards, G., Morrison, D. & Gould, I. M., 2002, In: Journal of Antimicrobial Chemotherapy. 50, 5, p. 689-697 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Teicoplanin 100%
  • Scotland 84%
  • Blood Culture 75%
  • Methicillin-Resistant Staphylococcus aureus 75%
  • Staphylococcus aureus 63%
  40 Citations (Scopus)

• Molecular epidemiology and antibiotic resistance of Enterobacter spp. from three distinct populations in Grampian, UK

  Wagenlehner, F. M., MacKenzie, F., Forbes, K. J. & Gould, I. M., 2002, In: International Journal of Antimicrobial Agents. 20, 6, p. 419-425 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Enterobacter 100%
  • Molecular Epidemiology 91%
  • Microbial Drug Resistance 77%
  • Cefotaxime 62%
  • Outpatients 39%
  6 Citations (Scopus)
• 2001

  Introduction: Antibiotic prophylaxis in clean surgery

  Gould, I. M., 2001, In: Journal of Chemotherapy. 13 Spec No 1, 1, p. 80-83 3 p.

  Research output: Contribution to journal › Article › peer-review

  1 Citation (Scopus)

• Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long-term antibiotic therapy

  Low, A. S., MacKenzie, F., Gould, I. M. & Booth, I. R., 2001, In: Molecular Microbiology. 42, 3, p. 619-630 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Anti-Bacterial Agents 100%
  • Cysts 88%
  • Focal Infection 77%
  • Molecular Evolution 65%
  • Microbial Drug Resistance 50%
  39 Citations (Scopus)
• 1999

  Assessment of the efficacy, safety and quality of gentamicin use in Aberdeen Royal Infirmary

  Buabeng, K. O., MacKenzie, A. R., Laing, R. B. S., Cook, I., Jappy, B. & Gould, I. M., 1999, In: Journal of Antimicrobial Chemotherapy. 44, p. 843-845 3 p.

  Research output: Contribution to journal › Article

  • Numbers Needed To Treat 100%
  • Gentamicins 83%
  • Safety 46%
  7 Citations (Scopus)

• Duration of intravenous therapy and hospital stay according to choice of empirical antimicrobial treatment for community-acquired respiratory infection

  Laing, R. B. S., MacKenzie, A. R., Shaw, H., Gould, I. M. & Douglas, J. G., 1999, In: International Journal of Antimicrobial Agents. 13, p. 53-56 4 p.

  Research output: Contribution to journal › Article

  • Community-Acquired Infections 100%
  • Duration of Therapy 70%
  • Respiratory Tract Infections 70%
  • Cephalosporins 57%
  • Length of Stay 57%
  3 Citations (Scopus)
• 1997

  Emergence of a carbapenem-resistant Klebsiella pneumoniae

  MacKenzie, F. M., Forbes, K. J., DoraiJohn, T., Amyes, S. G. B. & Gould, I. M., 13 Sept 1997, In: The Lancet. 350, 9080, p. 783 1 p.

  Research output: Contribution to journal › Article › peer-review
  93 Citations (Scopus)
• 1994

  Quinolone resistant Haemophilus influenzae

  Gould, I. M. & Forbes, K. J., Jan 1994, In: Journal of Antimicrobial Chemotherapy. 33, 1, p. 187-188 2 p.

  Research output: Contribution to journal › Letter › peer-review

  33 Citations (Scopus)